Sort
38,696 grants matching “als”
Molecular Chaperones and Protein Degradation
$545,790Alfred L Goldberg · Harvard Medical School · R01 · FY2018 · GM
Molecular Chaperones and Protein Degradation
$545,790Alfred L Goldberg · Harvard Medical School · R01 · FY2017 · GM
Molecular Chaperones and Protein Degradation
$545,790Alfred L Goldberg · Harvard Medical School · R01 · FY2019 · GM
Molecular Chaperones and Protein Degradation
$545,790Alfred L Goldberg · Harvard Medical School · R01 · FY2020 · GM
A taxonomic articulation-focused approach to dysarthria classification
$545,768Antje Mefferd · Vanderbilt University Medical Center · R01 · FY2023 · DC
Intervening in the Lives of Foster Care Youth: Using Integrative Data Analysis to Examine Crossover and Long-Term Mental Health Benefits of Dual-Focused CaregiverâYouth Preventative Interventions
$545,719Stacey S Tiberio · Oregon Social Learning Center, Inc. · R01 · FY2022 · MH
Intervening in the Lives of Foster Care Youth: Using Integrative Data Analysis to Examine Crossover and Long-Term Mental Health Benefits of Dual-Focused CaregiverâYouth Preventative Interventions
$545,719Stacey S Tiberio · Oregon Social Learning Center, Inc. · R01 · FY2021 · MH
Lymph node-targeted molecular vaccines for mucosal HIV immunity
$545,703Darrell J Irvine · Texas Biomedical Research Institute · P01 · FY2016 · AI
Effects of Hearing Status on Adult Speech Production
$545,702Joseph S Perkell · Massachusetts Institute Of Technology · R01 · FY2010 · DC
Optineurin dysfunction induces neurodegeneration in normal tension glaucoma by a novel molecular mechanism
$545,696Yang Hu · Stanford University · R01 · FY2024 · EY
Optineurin dysfunction induces neurodegeneration in normal tension glaucoma by a novel molecular mechanism
$545,696Yang Hu · Stanford University · R01 · FY2022 · EY
Optineurin dysfunction induces neurodegeneration in normal tension glaucoma by a novel molecular mechanism
$545,696Yang Hu · Stanford University · R01 · FY2023 · EY
Optineurin dysfunction induces neurodegeneration in normal tension glaucoma by a novel molecular mechanism
$545,696Yang Hu · Stanford University · R01 · FY2025 · EY
Identifying and understanding drivers of chemoresistance in small cell lung cancer
$545,661David Macpherson · Fred Hutchinson Cancer Center · R01 · FY2023 · CA
Identifying and understanding drivers of chemoresistance in small cell lung cancer
$545,661David Macpherson · Fred Hutchinson Cancer Center · R01 · FY2025 · CA
Small molecule mitochondria-targeted therapeutics for Huntingtons Disease
$545,636Eugenia Trushina · Mayo Clinic Rochester · R01 · FY2018 · NS
Small molecule mitochondria-targeted therapeutics for Huntingtons Disease
$545,636Eugenia Trushina · Mayo Clinic Rochester · R01 · FY2019 · NS
Growth differentiation control in primary keratinocytes
$545,543Gian Paolo Dotto · Massachusetts General Hospital · R01 · FY2010 · AR
Population-Based Study of Environmental Risk Factors for ALS
$545,438Marc G Weisskopf · Harvard School Of Public Health · R01 · FY2010 · ES
Effects of Opioid Use Disorder in Pregnancy on Long-Term Maternal and Child Outcomes
$545,265Senthilkumar Sadhasivam · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · HD
Eosinophils, Inflammation and Immunity
$545,204Helene Rosenberg · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Transport Processes and Nervous System Function
$545,072Peter J. Basser · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2021 · HD
Structural Studies of Alzheimer's beta-Amyloid Fibrils
$545,053Robert Tycko · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK
Intervention to Reduce Depression Among Elder Abuse Victims: Type 1 Hybrid Trial of Tele-PROTECT
$545,045Jo Anne Sirey · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · MH
Therapeutic targeting of IRAK4 in MDS
$545,024Amit Verma · Albert Einstein College Of Medicine · R01 · FY2022 · CA